BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Setia N, Alpert L, van der Sloot KW, Colussi D, Stewart KO, Misdraji J, Khalili H, Lauwers GY. Lymphocytic colitis: pathologic predictors of response to therapy. Human Pathology 2018;78:1-7. [DOI: 10.1016/j.humpath.2018.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn AM, Wildt S, Bohr J, Bonderup O, Bouma G, D'Amato M, Heiberg Engel PJ, Fernandez-Banares F, Macaigne G, Hjortswang H, Hultgren-Hörnquist E, Koulaouzidis A, Kupcinskas J, Landolfi S, Latella G, Lucendo A, Lyutakov I, Madisch A, Magro F, Marlicz W, Mihaly E, Munck LK, Ostvik AE, Patai ÁV, Penchev P, Skonieczna-Żydecka K, Verhaegh B, Münch A. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J 2021. [PMID: 33619914 DOI: 10.1177/2050640620951905] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
2 Khalili H, Burke KE, Roelstraete B, Sachs MC, Olén O, Ludvigsson JF. Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study. Gastroenterology 2020;158:1574-1583.e2. [PMID: 31926169 DOI: 10.1053/j.gastro.2019.12.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
3 Mihaly E, Patai Á, Tulassay Z. Controversials of Microscopic Colitis. Front Med (Lausanne) 2021;8:717438. [PMID: 34712675 DOI: 10.3389/fmed.2021.717438] [Reference Citation Analysis]
4 Olsen LM, Engel PJH, Goudkade D, Villanacci V, Thagaard J, Walbech JS, Bohr J, Kupcinskas J, Verhaegh B, Münch A, Guagnozzi D, Fernández-Bañares F, Munck LK, Fiehn AK. Histological disease activity in patients with microscopic colitis is not related to clinical disease activity or long-term prognosis. Aliment Pharmacol Ther 2021;54:43-52. [PMID: 34018208 DOI: 10.1111/apt.16381] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fiehn AK, Clausen LN, Engel U, Wildt S, Munck LK, Kristensson M, Engel PJH. Is revision of cutoff values needed when using CD3 immunohistochemical staining in histopathologic diagnosis of lymphocytic colitis? Human Pathology 2019;84:115-23. [DOI: 10.1016/j.humpath.2018.08.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]